Related Experiment Video
Updated: Aug 14, 2026
10:37
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
Published on: January 16, 2015
Biochemical links between cigarette smoking and pulmonary emphysema
Summary
Pulmonary emphysema may result from excessive lung tissue breakdown due to proteolysis. Cigarette smoking is a key factor, potentially triggering this process through chemical and cellular effects on elastin metabolism.
Area of Science:
- Pulmonary Medicine
- Biochemistry
- Environmental Health
Background:
- Pulmonary emphysema is characterized by alveolar effacement.
- Accumulating evidence suggests a link between unrestrained proteolytic activity and emphysema development.
- Cigarette smoking is a primary environmental risk factor for emphysema.
Purpose of the Study:
- To review observations linking the protease-pathogenesis model to cigarette smoking in emphysema.
- To place these observations within the framework of the protease model.
- To identify questions for future research on emphysema pathogenesis.
Main Methods:
- Review of existing scientific literature and observations.
- Analysis of the protease-pathogenesis model.
- Examination of the role of cigarette smoke in altered elastin metabolism.
Main Results:
- Circumstantial evidence suggests unrestrained proteolytic (elastolytic) activity contributes to alveolar effacement in emphysema.
- Cigarette smoke is implicated through chemical and cellular effects altering lung elastin metabolism.
- A connection is emerging between the protease model and smoking as a cause of emphysema.
Conclusions:
- The protease-pathogenesis model provides a framework for understanding emphysema.
- Cigarette smoking likely plays a significant role in emphysema development via protease dysregulation.
- Further research is needed to rigorously prove the protease hypothesis and elucidate smoking's precise mechanisms.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...